Skip to search formSkip to main contentSkip to account menu

NSC-109,724

Known as: NSC 109,724, NSC109724, NSC109,724 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ifosfamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1976
Highly Cited
1976
Studies on the human pharmacokinetics of isophosphamide (NSC-109724).
The pharmacokinetics of isophosphamide (IP) in man has been studied using 14C-labeled drug and differential extraction of… 
Highly Cited
1976
Highly Cited
1976
Studies on the metabolism of isopnosphamide (NSC-109724) in man.
  • K. Norpoth
  • Cancer treatment reports
  • 1976
  • Corpus ID: 35541919
A method is described for the quantitative determination of cyclophosphamide, isophosphamide, and trophosphamide and their stable… 
1976
1976
Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).
1975
1975
Phase I clinical trial of isophosphamide (NSC-109724).
An initial clinical phase I trial of isophosphamide has been carried out at dose levels of 200-10,000 mg/m2 of body surface area… 
1974
1974
Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
1974
1974
Renal dysfunction after treatment with isophosphamide (NSC-109724).
1973
1973
Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.
1972
1972
In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.
1972
1972
In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.
1972
1972
Comparison of the cardiovascular actions of NSC-109,724 (ifosfamide) and cyclophosphamide.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)